Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 1/20 | 0.73 |
| ▸ | F7 | P08709 | 2/20 | 0.63 |
| ▸ | F3 | P13726 | 2/20 | 0.63 |
| ▸ | LMNA | P02545 | 2/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.61 |
| ▸ | CNR2 | P34972 | 1/20 | 0.59 |
| ▸ | TERT | O14746 | 3/20 | 0.58 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.58 |
| ▸ | PPARG | P37231 | 3/20 | 0.58 |
| ▸ | PPARD | Q03181 | 3/20 | 0.58 |
| ▸ | PPARA | Q07869 | 3/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.58 |
| ▸ | MAPT | P10636 | 2/20 | 0.58 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.58 |
| ▸ | BLM | P54132 | 2/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.58 |
| ▸ | FABP4 | P15090 | 2/20 | 0.58 |
| ▸ | FAAH | O00519 | 2/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.58 |
| ▸ | GMNN | O75496 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28248477 | 1.00 | EPHX2 (0.73) | EPHX2F7F3LMNAALDH1A1 | |
| SCHEMBL10444384 | 1.00 | EPHX2 (0.73) | EPHX2F7F3LMNAALDH1A1 | |
| SCHEMBL3705115 | 1.00 | EPHX2 (0.73) | EPHX2F7F3LMNAALDH1A1 | |
| SCHEMBL28495765 | 1.00 | EPHX2 (0.73) | EPHX2F7F3LMNAALDH1A1 | |
| SCHEMBL583629 | 1.00 | EPHX2 (0.73) | EPHX2F7F3LMNAALDH1A1 | |
| SCHEMBL28813484 | 1.00 | EPHX2 (0.73) | EPHX2F7F3LMNAALDH1A1 | |
| SCHEMBL583630 | 1.00 | EPHX2 (0.73) | EPHX2F7F3LMNAALDH1A1 | |
| SCHEMBL30801443 | 1.00 | EPHX2 (0.73) | EPHX2F7F3LMNAALDH1A1 | |
| SCHEMBL31512544 | 1.00 | EPHX2 (0.73) | EPHX2F7F3LMNAALDH1A1 | |
| SCHEMBL28344532 | 1.00 | EPHX2 (0.73) | EPHX2F7F3LMNAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 131 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025090952-A1 | DESATURASE VARIANTS AND METHODS OF USE | GENOMATICA, INC. (US) | 2025-05-01 | — | — | WO | claimed |
| CN-119827660-A | Identification method of kitchen waste grease | 武汉食品化妆品检验所 | 2025-04-15 | — | — | CN | claimed |
| US-20240287015-A1 | Method for Producing an Ionizable Lipid | NANOVATION THERAPEUTICS INC. (CA) | 2024-08-29 | — | — | US | claimed |
| CN-116660543-A | Diagnostic and prognostic markers for nonalcoholic fatty liver disease and uses thereof | 中国人民解放军陆军军医大学第一附属医院 | 2023-08-29 | — | — | CN | claimed |
| EP-3377465-B1 | PRODUCTION OF FATTY OLEFIN DERIVATIVES VIA OLEFIN METATHESIS | PROVIVI INC (US) | 2023-08-02 | — | — | EP | claimed |
| CN-115404118-B | Aluminum shell stretching oil composition | 季华实验室 | 2023-04-18 | — | — | CN | claimed |
| WO-2022246555-A1 | METHOD FOR PRODUCING AN IONIZABLE LIPID | NANOVATION THERAPEUTICS INC. (CA) | 2022-12-01 | — | — | WO | claimed |
| CN-115404118-A | Aluminum shell stretching oil composition | 季华实验室 | 2022-11-29 | — | — | CN | claimed |
| CN-115215748-A | Production of aliphatic olefin derivatives by olefin metathesis | 普罗维维公司 | 2022-10-21 | — | — | CN | claimed |
| CN-108473390-B | Production of aliphatic olefin derivatives by olefin metathesis | 普罗维维公司 | 2022-08-09 | — | — | CN | claimed |
| CN-109999019-B | Application of myristoleic acid methyl ester in preparation of product for preventing or treating metabolic syndrome or improving body energy metabolism | 中国科学院动物研究所 | 2021-11-16 | — | — | CN | claimed |
| US-9776179-B2 | Production of fatty olefin derivatives via olefin metathesis | PROVIVI, INC. (US) | 2017-10-03 | — | — | US | claimed |
| US-20170137365-A1 | PRODUCTION OF FATTY OLEFIN DERIVATIVES VIA OLEFIN METATHESIS | PROVIVI, INC. (US) | 2017-05-18 | — | — | US | claimed |
| WO-2008005831-A2 | COMPOSITIONS OF PPO-INHIBITING COMPOUNDS AND N-ALKYLPYRROLIDONES | FMC CORPORATION (US) | 2008-01-10 | — | — | WO | claimed |
| WO-2026104850-A1 | POLYOL ESTERS | INNOSPEC LIMITED (GB) | 2026-05-21 | — | — | WO | disclosed |
| WO-2026104830-A1 | USES AND COMPOSITIONS | INNOSPEC LIMITED (GB) | 2026-05-21 | — | — | WO | disclosed |
| WO-2026104852-A1 | USE OF A POLYOL ESTER FOR INCREASED WATER REPELLENCY, REDUCED FRICTION, OR IMPROVED VISUAL APPEARANCE, METHOD OF TREATING A SURFACE, COMPOSITION AND TREATED SUBSTRATE | INNOSPEC LIMITED (GB) | 2026-05-21 | — | — | WO | disclosed |
| US-4185027-A | Hydrolysis of methyl esters | THE PROCTER & GAMBLE COMPANY (US) | 1980-01-22 | — | — | US | disclosed |
| EP-0002545-A1 | Process for separating esters of fatty acids by degree of unsaturation | THE PROCTER & GAMBLE COMPANY (US) | 1979-06-27 | — | — | EP | disclosed |
| EP-0001854-A2 | Process for separating unsaturated and saturated fatty acid esters | THE PROCTER & GAMBLE COMPANY (US) | 1979-05-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170137365-A1 | PRODUCTION OF FATTY OLEFIN DERIVATIVES VIA OLEFIN METATHESIS | SREBF1, F2, SREBF2 | EPHX2 929/4885F7 70/4885F3 72/4885 |
| US-20240287015-A1 | Method for Producing an Ionizable Lipid | CEL, FASN, COASY | EPHX2 1060/4885F7 259/4885F3 1378/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.